Literature DB >> 3337051

Differential lectin staining of central and peripheral zones of the prostate and alterations in dysplasia.

J E McNeal1, I Leav, J Alroy, E Skutelsky.   

Abstract

Histochemical staining with a battery of ten lectins demonstrated differences in lectin binding patterns between seminal vesicle, prostatic central and peripheral zones, and foci of prostate intraductal dysplasia, a putative premalignant lesion. Lectin binding patterns of seminal vesicle and central zone of the prostate were identical except for a single lectin, supporting the concept that these two structures have a common embryologic origin from the wolffian duct. Three of the lectins that bound to central zone were not bound in peripheral zone, indicating a biologic difference between these two regions of the prostate. Dysplasia foci showed markedly reduced binding with all lectins, consistent with impaired processing of glyco-conjugates. Lectin binding patterns appear to have value as sensitive markers of differences in terminal differentiation of closely related tissues and of early impairment of differentiated function in lesions that are precursors to carcinoma. Specific patterns of lectin binding provide information on the differential carbohydrate composition of the regions of the prostate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3337051     DOI: 10.1093/ajcp/89.1.41

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

1.  Expression of P-cadherin identifies prostate-specific-antigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas. Implications for prostate cancer biology.

Authors:  A P Soler; G D Harner; K A Knudsen; F X McBrearty; E Grujic; H Salazar; A C Han; A A Keshgegian
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma.

Authors:  I Leav; K M Lau; J Y Adams; J E McNeal; M E Taplin; J Wang; H Singh; S M Ho
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Characterization of corpora amylacea glycoconjugates in normal and hyperplastic glands of human prostate.

Authors:  Eva Morales; Luis A Polo; Luis M Pastor; Luis Santamaría; Alfonso Calvo; Adelina Zuasti; Concepción Ferrer
Journal:  J Mol Histol       Date:  2005-05       Impact factor: 2.611

Review 4.  A historical perspective on the role of stroma in the pathogenesis of benign prostatic hyperplasia.

Authors:  Gerald R Cunha; William A Ricke
Journal:  Differentiation       Date:  2011-06-30       Impact factor: 3.880

5.  A lectin histochemistry comparative study in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.

Authors:  M I Arenas; E Romo; I de Gaspar; F R de Bethencourt; M Sánchez-Chapado; B Fraile; R Paniagua
Journal:  Glycoconj J       Date:  1999-07       Impact factor: 2.916

Review 6.  Alpha-adrenoceptor antagonists in the treatment of benign prostatic hyperplasia.

Authors:  K L Cooper; J M McKiernan; S A Kaplan
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

7.  Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma.

Authors:  R B Nagle; M K Brawer; J Kittelson; V Clark
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

8.  Lectin histochemical study of the prostate gland of the rhesus monkey (Macaca mulatta).

Authors:  S Wakui; M Furusato; Y Nomura; M Asari; Y Kano
Journal:  J Anat       Date:  1992-08       Impact factor: 2.610

9.  Protective effect of Chuquiraga spinosa extract on N-methyl-nitrosourea (NMU) induced prostate cancer in rats.

Authors:  Jorge Arroyo-Acevedo; Oscar Herrera-Calderón; Roberto Chávez-Asmat; Andrea Anampa-Guzmán; Víctor Chumpitaz-Cerrate; Edwin Enciso-Roca
Journal:  Prostate Int       Date:  2017-01-17

10.  Differences in microRNA expression during tumor development in the transition and peripheral zones of the prostate.

Authors:  Jessica Carlsson; Gisela Helenius; Mats G Karlsson; Ove Andrén; Karin Klinga-Levan; Björn Olsson
Journal:  BMC Cancer       Date:  2013-07-29       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.